Circulation, Vol 86, 71-80, Copyright © 1992 by American Heart Association
JA Bittl and TA Sanborn
BACKGROUND. Excimer laser coronary angioplasty has been reported to be a
promising treatment for complex coronary artery disease. The purpose of
this study was to define the predictors of acute success and restenosis
after this experimental intervention. METHODS AND RESULTS. A cohort of 200
consecutive patients had a minimum of 6 months of follow- up evaluation
after treatment of 215 coronary stenoses that were carefully selected for
excimer laser coronary angioplasty. At the time of the initial procedure,
the laser catheter alone produced a residual stenosis of less than or equal
to 50% at 119 of 215 lesions (55.4%). For complete dilatation, 87.9% of the
lesions required adjunctive balloon angioplasty. Clinical success was
achieved in 183 of the 200 patients (91.5%), as indicated by a reduction by
at least 20% of the narrowing of the vessel diameter, less than or equal to
50% residual stenosis, and no in-hospital complication. Complications
included abrupt closure (5.0%), myocardial infarction (3.5%), bypass
surgery (3.0%), perforation (2.0%), and death (0.0%). Logistic regression
analysis showed that lesions at vessel bifurcations (success rate, 66%;
adjusted odds ratio [OR] = 0.16; p = 0.002) or in tortuous vessels (success
rate, 82%; OR = 0.48; p = 0.004) were associated with decreased clinical
success. However, acceptable success rates were achieved in patients with
lesions in saphenous vein grafts more than 3 years old (success rate, 94%;
OR = 1.40; p = 0.75), in ostial lesions (success rate, 100%; OR = 3.36; p =
0.43), and in lesions longer than 10 mm (success rate, 93.5%; OR = 1.50; p
= 0.39). Clinical follow-up was available in 197 of the 200 patients
(98.5%) a mean of 5.9 +/- 1.9 months after angioplasty, at which time 31.0%
of patients had developed symptoms or evidence of ischemia. No patient died
during the study. Follow-up angiography was obtained in 83.1% of eligible
patients after a mean [+/- SD] of 5.2 +/- 2.0 months. Angiographic
restenosis, defined by greater than 50% stenosis, appeared at 78 of 164
lesions (47.6%). By logistic regression analysis, only lesions in saphenous
vein grafts were associated with a decreased rate of restenosis (restenosis
rate, 20%; OR = 0.18; p = 0.01). CONCLUSIONS. This analysis, which defines
the profile of risk for excimer laser angioplasty, provides a sound basis
for rigorous comparison of adjunctive excimer laser with balloon
angioplasty for ostial narrowings, long lesions, and saphenous vein graft
stenoses.
ARTICLES
Excimer laser-facilitated coronary angioplasty. Relative risk analysis of acute and follow-up results in 200 patients
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
This article has been cited by other articles:
![]() |
A K Mitra and D K Agrawal In stent restenosis: bane of the stent era. J. Clin. Pathol., March 1, 2006; 59(3): 232 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ahmed, M. K. Hong, R. Mehran, G. S. Mintz, A. J. Lansky, A. D. Pichard, L. F. Satler, K. M. Kent, H. Wu, G. W. Stone, et al. Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1560 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Betriu, M. Masotti, A. Serra, J. Alonso, F. Fernandez-Aviles, F. Gimeno, T. Colman, J. Zueco, J. L. Delcan, E. Garcia, et al. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): A four-year follow-up J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1498 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Visona, C. Perissinotto, L. Lusiani, A. Bonanome, R. Pesavento, L. Miserocchi, G. Liessi, and A. Pagnan Percutaneous Excimer Laser Angioplasty of Lower Limb Vessels: Results of a Prospective 24-Month Follow-up Angiology, February 1, 1998; 49(2): 91 - 98. [Abstract] [PDF] |
||||
![]() |
Y. E A Appelman, J. J Piek, W. K Redekop, P. J de Feyter, J. J Koolen, G. K David, S. Strikwerda, J. G P Tijssen, P. W Serruys, E v Swijndregt, et al. Clinical events following excimer laser angioplasty or balloon angioplasty for complex coronary lesions: subanalysis of a randomised trial Heart, January 1, 1998; 79(1): 34 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mehran, G. S. Mintz, L. F. Satler, A. D. Pichard, K. M. Kent, T. A. Bucher, J. J. Popma, and M. B. Leon Treatment of In-Stent Restenosis With Excimer Laser Coronary Angioplasty : Mechanisms and Results Compared With PTCA Alone Circulation, October 7, 1997; 96(7): 2183 - 2189. [Abstract] [Full Text] |
||||
![]() |
G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, Y. Chien Chuang, R. A. DeFalco, and M. B. Leon Limitations of Angiography in the Assessment of Plaque Distribution in Coronary Artery Disease : A Systematic Study of Target Lesion Eccentricity in 1446 Lesions Circulation, March 1, 1996; 93(5): 924 - 931. [Abstract] [Full Text] |
||||
![]() |
G. S. Mintz, J. A. Kovach, S. P. Javier, A. D. Pichard, K. M. Kent, J. J. Popma, L. F. Salter, and M. B. Leon Mechanisms of Lumen Enlargement After Excimer Laser Coronary Angioplasty : An Intravascular Ultrasound Study Circulation, December 15, 1995; 92(12): 3408 - 3414. [Abstract] [Full Text] |
||||
![]() |
B. H. Strauss, M. K. Natarajan, W. B. Batchelor, D. E. Yardley, J. A. Bittl, T. A. Sanborn, J. A. Power, L. E. Watson, R. Moothart, J. E. Tcheng, et al. Early and Late Quantitative Angiographic Results of Vein Graft Lesions Treated by Excimer Laser With Adjunctive Balloon Angioplasty Circulation, August 1, 1995; 92(3): 348 - 356. [Abstract] [Full Text] |
||||
![]() |
J. A. Bittl Directional Coronary Atherectomy versus Balloon Angioplasty N. Engl. J. Med., July 22, 1993; 329(4): 273 - 274. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |